New lites order task order 0010 cavalier trial
Ended Awarded Last action
- Contract number
- W81XWH22F0118
- Awardee
-
University Of Pittsburgh - Of The Commonwealth System Of Higher Education UEI MKAGLD59JRL1
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $11,999,380
Award facts
- Opportunity
-
- W81XWH16R0033 Solicitation number
- Contract value 100% obligated
- $11,999,380.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Pittsburgh, PA 15260, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $4,028,570 | |
| Original award | $7,970,810 |
About this award
The Defense Health Agency issued a delivery order to the University of Pittsburgh on September 22, 2022, with a ceiling value of $11,999,380 for the LITES Study Task Order 0010 CAVALIER (Calcium and Vasopressin Following Injury Early Resuscitation) clinical trial, a multi-year Phase II double-blinded, multi-center, prehospital and early in-hospital randomized trial. The order carries cost-no-fee pricing and is set to complete on September 22, 2026.
Place of performance is Pittsburgh, PA. The trial is designed to determine whether prehospital calcium supplementation, early in-hospital vasopressin infusion, or both as compared to placebo result in lower 30-day mortality in patients at risk of hemorrhagic shock. Secondary objectives assess 6-hour, 24-hour, and in-hospital mortality; death from hemorrhage and brain injury; transfusion requirements; Multiple Organ Failure incidence; nosocomial infection rates; time to hemostasis; coagulopathy by thromboelastography; and ICU-free and hospital-free days.
Subcontractors functioning as clinical trial sites include the University of Washington, University of Miami, University of Colorado-Denver, The Ohio State University, University of New Mexico Health Sciences Center, Denver Health and Hospital Authority, Hennepin Healthcare Research Institute, University of Maryland Baltimore, University of Missouri, University of Arkansas for Medical Sciences, University of Mississippi Medical Center, Allegheny Singer Research Institute, Dignity Community Care, Mount Carmel Health System, University of Arizona, and Texas Tech University Health Sciences Center. The multi-site enrollment spans 11 Level I trauma centers across the United States.
Subawards
Show all 24
Quick answers
Who was awarded contract W81XWH22F0118?
W81XWH22F0118 was awarded to University Of Pittsburgh - Of The Commonwealth System Of Higher Education by Defense Health Agency (Department of Defense) on September 22, 2022.
How much is contract W81XWH22F0118 worth?
The government has obligated $11,999,380 on W81XWH22F0118.
Is contract W81XWH22F0118 an order under another contract?
Yes. W81XWH22F0118 is a delivery order under W81XWH16D0024, an indefinite delivery contract.
Was contract W81XWH22F0118 competed?
The extent of competition for W81XWH22F0118 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award